BARUTTA, Federica

BARUTTA, Federica  

SCIENZE MEDICHE  

Mostra records
Risultati 1 - 20 di 70 (tempo di esecuzione: 0.022 secondi).
Titolo Data di pubblicazione Autore(i) File
Anti-HSP70 levels and the metabolic syndrome: the Casale Monferrato Study 2012 Lorenzati B; Giunti S; Barutta F; PInach S; Cavallo Perin P; Bruno G; Gruden G
Association of serum MicroRNA-145-5p levels with microvascular complications of type 1 Diabetes: The EURODIAB prospective complications study 2022 Barutta, Federica; Bellini, Stefania; Guarrera, Simonetta; Matullo, Giuseppe; Schalkwijk, Casper; Stehouwer, Coen D; Chaturvedi, Nish; Soedamah-Muthu, Sabita S; Durazzo, Marilena; Gruden, Gabriella
Associazione tra anti-HSP70 e sindrome plurimetabolica: il Casale Monferrato Study 2012 Lorenzati B; Giunti S; Barutta F; Pinach S; Amione C; Tricarico M; Landi A; Schimmenti A; Cavallo Perin P; Bruno G; Gruden G
ATTIVAZIONE DEL RECETTORE CB2 E NEFROPATIA DIABETICA SPERIMENTALE 2010 Barutta F; Gambino R; Pinach S; Cavallo Perin P; Gruden G
Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy 2010 Barutta F; Corbelli A; Mastrocola R; Gambino R; Di Marzo V; Pinach S; Rastaldi MP; Perin PC; Gruden G.
Cannabinoid Receptors in Diabetic Kidney Disease 2018 Barutta F.; Mastrocola R.; Bellini S.; Bruno G.; Gruden G.
Circulating anti-Hsp70 levels in nascent metabolic syndrome: the Casale Monferrato Study. 2013 Gruden G; Barutta F; Pinach S; Lorenzati B; Cavallo-Perin P; Giunti S; Bruno G.
The co-activator-associated arginine methyltransferase 1 (CARM1) gene is overexpressed in type 2 diabetes. 2019 Massimo Porta, Cristina Amione, Federica Barutta, Paolo Fornengo, Stefano Merlo, Gabriella Gruden, Luigi Albano, Marco Ciccarelli, Paola Ungaro, Marilena Durazzo, Francesco Beguinot, Paola Berchialla, Franco Cavallo, Marina Trento.
Co-activator-associated arginine methyltransferase 1 (CARM1) is overexpressed in type 2 diabetes. 2017 Porta, M; Amione, C; Barutta, F; Albano, L; Ciccarelli, M; Fornengo, P; Merlo, S; Ungaro, P; Beguinot, F; Berchialla, P; Cavallo, F; Trento, M.
Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice 2014 Barutta F; Grimaldi S; Franco I; Bellini S; Gambino R; Pinach S; Corbelli A; Bruno G; Rastaldi MP; Aveta T; Hirsch E; Di Marzo V; Gruden G
Deletion of RAGE fails to prevent hepatosteatosis in obese mice due to impairment of other AGEs receptors and detoxifying systems 2021 Wouters K.; Cento A.S.; Gaens K.H.; Teunissen M.; Scheijen J.L.J.M.; Barutta F.; Chiazza F.; Collotta D.; Aragno M.; Gruden G.; Collino M.; Schalkwijk C.G.; Mastrocola R.
Diabetes-specific variables associated with quality of life changes in young diabetic people: the type 1 diabetes Registry of Turin (Italy) 2013 M. Trento; F. Panero;M. Porta;G. Gruden;F. Barutta;F. Cerutti;R. Gambino;M. Perotto;P. Cavallo Perin;G. Bruno
Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function” 2019 Pugliese G.; Penno G.; Natali A.; Barutta F.; Di Paolo S.; Reboldi G.; Gesualdo L.; De Nicola L.
Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function” 2020 Pugliese G.; Penno G.; Natali A.; Barutta F.; Di Paolo S.; Reboldi G.; Gesualdo L.; De Nicola L.
Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy 2017 Barutta, Federica; Grimaldi, Serena; Gambino, Roberto; Vemuri, Kiran; Makriyannis, Alexandros; Annaratone, Laura; di Marzo, Vincenzo; Bruno, Graziella; Gruden, Gabriella
Early life socioeconomic indicators and the risk of type 1 diabetes in children and young adults 2013 Bruno G; Spadea T; Picariello R; Gruden G; Barutta F; Cerutti F; Cavallo-Perin p; Costa G; Gnavi R; Piedmont Study Group for Diabetes Epidemiology.
The Effect of Age and NT-proBNP on the Association of Central Obesity with 6-Years Cardiovascular Mortality of Middle-Aged and Elderly Diabetic People: The Population-Based Casale Monferrato Study 2014 Bruno G; Barutta F; Landi A; Cavallo Perin P; Gruden G
Effect of CB2 Receptor Activation in Experimental Diabetic Nephropathy 2010 Barutta F; Gambino R; Pinach S; Cavallo Perin P; Gruden G
Effect of CB2 receptor deletion in streptozotocin-induced diabetic mice 2011 Barutta F; Corbelli A; Pinach S; Rastaldi MP; Cavallo Perin P; Gruden G
Effect of the MCP-1/CCR2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes 2009 Tarabra E; Giunti S; Barutta F; Salvidio G; Burt D; Deferrari G; Gambino R; Vergola D; Pinach S; Cavallo Perin P; Camussi G; Gruden G.